Literature DB >> 2417354

Plasma concentrations of platelet-specific proteins in different stages of essential hypertension: interactions between platelet aggregation, blood lipids and age.

J Yamanishi, H Sano, K Saito, Y Furuta, H Fukuzaki.   

Abstract

Plasma beta-thromboglobulin (beta TG) and platelet factor 4 (PF4) were significantly higher in a group of 116 hypertensive men than in a normotensive group of 142 men. They increased with the stage of hypertension but the level did not correlate with the age of the subjects. Platelet aggregation was similar in the two groups and positively correlated with the age of the subjects in the normotensive group but not in the hypertensive group. A strong positive correlation was observed between the levels of plasma beta TG and PF4 and between platelet aggregation to ADP and that to epinephrine in both the hypertensive and normotensive groups. However, there was no correlation between the level of plasma beta TG or PF4 and platelet aggregation. Plasma antithrombin III was lower in the hypertensive group than in the normotensive group. These studies suggest that plasma levels of beta TG and PF4 are closely related to the stage of hypertension and are better indicators than aggregation of in vivo platelet activation in hypertensive subjects. Enhanced platelet activation may be involved in the acceleration of hypertensive arteriovascular damage and atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2417354

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  6 in total

1.  Dose-dependent effects of verapamil and nifedipine on in vivo platelet function in normal volunteers.

Authors:  K Winther; C M Jespersen; B Rydberg; G Thamsborg; T Hedner
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Serotonin and platelet aggregation in patients with essential hypertension compared with a normotensive control group.

Authors:  D J Stott; A R Saniabadi; G C Inglis; J Hosie; G D Lowe; S G Ball
Journal:  Drugs       Date:  1988       Impact factor: 9.546

3.  Impaired uptake of 5 hydroxytryptamine platelet in essential hypertension: clinical relevance.

Authors:  N Fetkovska; A Pletscher; F Ferracin; R Amstein; F R Buhler
Journal:  Cardiovasc Drugs Ther       Date:  1990-01       Impact factor: 3.727

Review 4.  Can proteomics yield insight into aging aorta?

Authors:  Zongming Fu; Mingyi Wang; Allen Everett; Edward Lakatta; Jennifer Van Eyk
Journal:  Proteomics Clin Appl       Date:  2013-07-19       Impact factor: 3.494

5.  Profiling Heparin-Induced Thrombocytopenia (HIT) Antibodies in Hospitalized Patients With and Without Diabetes.

Authors:  Margaret Prechel; Susan Hudec; Elizabeth Lowden; Vicki Escalante; Nicholas Emanuele; Maryann Emanuele; Jeanine M Walenga
Journal:  Clin Appl Thromb Hemost       Date:  2018-11-12       Impact factor: 2.389

6.  Emphasis on the Role of PF4 in the Incidence, Pathophysiology and Treatment of Heparin Induced Thrombocytopenia.

Authors:  M Margaret Prechel; Jeanine M Walenga
Journal:  Thromb J       Date:  2013-04-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.